Visual Field Restoration in Patients With Post-stroke Homonymous Hemianopsia

Hemianopsia Clinical Trial

— REVOIR  

Official title:

Visual Field Restoration in Patients With Post-stroke Homonymous Hemianopsia

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT02886663
• Other study ID #: OGT_2015_16
• Status: Terminated
• Phase: N/A
• Start date: December 13, 2016
• Est. completion date: November 25, 2019

Study information

• Verified date: December 2019
• Source: Fondation Ophtalmologique Adolphe de Rothschild
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study will assess the effectiveness of a stimulus, in the blind field of hemianopsic patients, to restore the vision of patients with homonymous hemianopsia consecutive to stroke (unilateral occipital lesion). Hemianopsia occurs in 30% of strokes regardless of the cerebral localization and in 60% of stroke interesting the territory of the posterior cerebral artery.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 9
• Est. completion date: November 25, 2019
• Est. primary completion date: November 25, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Presence of an homonymous visual field amputation after vascular retrochiasmatic lesion of the occipital region (visual cortex alone or with optical radiations or with other associated occipital areas)

• inclusion 3 months to 36 months after stroke

• Patients aged 18 years and older

Exclusion criteria:

• Brain injury history

• Severe neuropsychological, psychiatric or behavioral disorder

• Severe eye disorder or visual impairment (visual acuity less than 3/10)

• Progressive eye disorder (cataracts or glaucoma)

• insufficient French language proficiency to understand the questionnaires and rehabilitation tasks

• patient under legal protection

• patient's opposition to participate in the study

• no medical insurance coverage

• pregnant pr breastfeeding patient

Related Conditions & MeSH terms

• Hemianopsia

Intervention

Other:
• stimulation of the blind visual field

Locations

Country	Name	City	State
France	Fondation Ophtalmologique Adolphe de Rothschild	Paris

Sponsors (1)

Lead Sponsor	Collaborator
Fondation Ophtalmologique Adolphe de Rothschild

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	change in the sensitivity of detection of a visual stimulus after rehabilitation	change in the mean number of points where the sensitivity is lower than 15db in each contralesional hemifield, before and after rehabilitation	change from baseline sensitivity at week 22